Old, the new, more or less and the conundrum for biomarkers in cardiovascular diseases?

IF 1 4区医学 Q3 MEDICINE, GENERAL & INTERNAL

World Journal of Clinical Cases Pub Date : 2024-10-06 DOI:10.12998/wjcc.v12.i28.6244

Pupalan Iyngkaran

引用次数: 0

Abstract

Biomarkers are critical for diagnostic, monitoring and management of cardiovascular diseases. Opportunities to improve how biomarkers are used are important. This editorial on biomarkers in coronary artery disease provides commentary on the study as well as broad benchmarks on what make ideal biomarkers. Biomarker discovery is difficult and opportunities to expand and improve their use should be encouraged.

查看原文本刊更多论文

心血管疾病生物标志物的新旧、多寡与难题？

生物标志物对于心血管疾病的诊断、监测和管理至关重要。改进生物标记物的使用方法非常重要。这篇关于冠状动脉疾病生物标志物的社论对这项研究进行了评论，并提供了理想生物标志物的广泛基准。生物标志物的发现是困难的，应鼓励扩大和改进其使用的机会。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

World Journal of Clinical Cases Medicine-General Medicine

自引率

0.00%

发文量

3384

期刊介绍： The World Journal of Clinical Cases (WJCC) is a high-quality, peer reviewed, open-access journal. The primary task of WJCC is to rapidly publish high-quality original articles, reviews, editorials, and case reports in the field of clinical cases. In order to promote productive academic communication, the peer review process for the WJCC is transparent; to this end, all published manuscripts are accompanied by the anonymized reviewers’ comments as well as the authors’ responses. The primary aims of the WJCC are to improve diagnostic, therapeutic and preventive modalities and the skills of clinicians and to guide clinical practice in clinical cases.